Organ Preservation Market - 2026-2033
Organ Preservation Market reached US$ 292.20 million in 2025 and is expected to reach US$ 463.90 million by 2033, growing with a CAGR of 5.86% during the forecast period 2026-2033.
The Organ Preservation Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Organ Preservation Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Technique
Both primary and secondary data sources have been used in the global Organ Preservation Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Organ Preservation Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Organ Preservation Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Technique
- Static Cold Storage (SCS)
- Hypothermic Perfusion Preservation (HPP)
- Normothermic Machine Perfusion
- Others
- University of Wisconsin Solution (UW Solution)
- Custodiol HTK
- Perfadex
- Collins Solution
- Citrate Solutions
- Others
- Kidneys
- Liver
- Lung
- Heart
- Other Organs (Pancreas, Intestine)
- Hospitals
- Specialty Clinics
- Transplant Centres
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Organ Preservation Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. MARKET DYNAMICS
3.1. Market Impacting Factors
3.1.1. Drivers
3.1.1.1. The increase in research and development by biopharmaceutical and pharmaceutical companies
3.1.2. Restraints:
3.1.2.1. High cost associated with the Organ Transplantation
3.1.2.2. Shortage in supply of organs
3.1.3. Opportunity
3.1.4. Impact Analysis
4. INDUSTRY ANALYSIS
4.1. Porter’s Five Forces
4.2. Unmet Needs
4.3. Epidemiology
4.4. Supply chain Analysis
4.5. Regulatory Analysis
5. COVID-19 ANALYSIS
5.1. Analysis of Covid-19 on the Market
5.1.1. Before COVID-19 Market Scenario
5.1.2. Present COVID-19 Market Scenario
5.1.3. After COVID-19 or Future Scenario
5.2. Pricing Dynamics Amid Covid-19
5.3. Demand-Supply Spectrum
5.4. Government Initiatives Related to the Market During Pandemic
5.5. Manufacturers Strategic Initiatives
5.6. Conclusion
6. BY TECHNIQUE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
6.1.2. Market Attractiveness Index, By Technique
6.2. Static Cold Storage (SCS)
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
6.3. Hypothermic Perfusion Preservation (HPP)
6.4. Normothermic Machine Perfusion
6.5. Others
7. BY PRESERVATION SOLUTION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
7.1.2. Market Attractiveness Index, By Preservation Solution
7.2. University of Wisconsin Solution (UW Solution)
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
7.3. Custodiol HTK
7.4. Perfadex
7.5. Collins Solution
7.6. Citrate Solutions
7.7. Others
8. BY ORGAN TYPE
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Organ Type
8.1.2. Market Attractiveness Index, By Organ Type Segment
8.2. Kidneys
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
8.3. Liver
8.4. Lung
8.5. Heart
8.6. Other Organs (Pancreas, Intestine)
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031, By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
9.3. Specialty Clinics
9.4. Transplant Centres
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. COMPETITIVE LANDSCAPE
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch
12. COMPANY PROFILES
12.1. Xvivo Perfusion AB
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. CryoLife, Inc.
12.3. Lifeline Scientific
12.4. BioTime, Inc.
12.5. Claris Lifesciences Limited
12.6. BioLife Solutions, Inc.
12.7. Dr. Franz Kohler Chemie GmbH
12.8. Bristol-Myers Squibb
12.9. Tolerotech, Inc.
12.10. 21st Century Medicine(*LIST NOT EXHAUSTIVE)
13. DATAM INTELLIGENCE
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. MARKET DYNAMICS
3.1. Market Impacting Factors
3.1.1. Drivers
3.1.1.1. The increase in research and development by biopharmaceutical and pharmaceutical companies
3.1.2. Restraints:
3.1.2.1. High cost associated with the Organ Transplantation
3.1.2.2. Shortage in supply of organs
3.1.3. Opportunity
3.1.4. Impact Analysis
4. INDUSTRY ANALYSIS
4.1. Porter’s Five Forces
4.2. Unmet Needs
4.3. Epidemiology
4.4. Supply chain Analysis
4.5. Regulatory Analysis
5. COVID-19 ANALYSIS
5.1. Analysis of Covid-19 on the Market
5.1.1. Before COVID-19 Market Scenario
5.1.2. Present COVID-19 Market Scenario
5.1.3. After COVID-19 or Future Scenario
5.2. Pricing Dynamics Amid Covid-19
5.3. Demand-Supply Spectrum
5.4. Government Initiatives Related to the Market During Pandemic
5.5. Manufacturers Strategic Initiatives
5.6. Conclusion
6. BY TECHNIQUE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
6.1.2. Market Attractiveness Index, By Technique
6.2. Static Cold Storage (SCS)
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
6.3. Hypothermic Perfusion Preservation (HPP)
6.4. Normothermic Machine Perfusion
6.5. Others
7. BY PRESERVATION SOLUTION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
7.1.2. Market Attractiveness Index, By Preservation Solution
7.2. University of Wisconsin Solution (UW Solution)
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
7.3. Custodiol HTK
7.4. Perfadex
7.5. Collins Solution
7.6. Citrate Solutions
7.7. Others
8. BY ORGAN TYPE
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Organ Type
8.1.2. Market Attractiveness Index, By Organ Type Segment
8.2. Kidneys
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
8.3. Liver
8.4. Lung
8.5. Heart
8.6. Other Organs (Pancreas, Intestine)
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031, By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031
9.3. Specialty Clinics
9.4. Transplant Centres
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2022-2031 and Y-o-Y Growth Analysis (%), 2023-2031, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. COMPETITIVE LANDSCAPE
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch
12. COMPANY PROFILES
12.1. Xvivo Perfusion AB
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. CryoLife, Inc.
12.3. Lifeline Scientific
12.4. BioTime, Inc.
12.5. Claris Lifesciences Limited
12.6. BioLife Solutions, Inc.
12.7. Dr. Franz Kohler Chemie GmbH
12.8. Bristol-Myers Squibb
12.9. Tolerotech, Inc.
12.10. 21st Century Medicine(*LIST NOT EXHAUSTIVE)
13. DATAM INTELLIGENCE
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
